To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene SLC25A37TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
593 representative clones for gene SLC25A37 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DB057758 testis SLC25A37.a 1 to 501 2 to 503   tiling clone, capped   502/502
(100 %)
2 diff
(99.7 %id)
DB009558 colon, tumor tissue SLC25A37.a 11 to 561 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
BI460337 testis SLC25A37.a 46 to 773 1 to 728       728/729
(99 %)
8 diff
(99.0 %id)
NM_016612.2   SLC25A37.a 55 to 1919 1 to 1865 exact RefSeq,   1865/1865
(100 %)
0 diff
(100 %id)
DB027322 testis SLC25A37.a 61 to 527 2 to 468   capped   467/467
(100 %)
1 diff
(99.8 %id)
BQ949957 sciatic nerve SLC25A37.a 75 to 624 1 to 558       558/1161
(48 %)
16 diff
(98.7 %id)
BJ993085 hepatoblastoma SLC25A37.a 78 to 497 1 to 420       420/420
(100 %)
1 diff
(99.8 %id)
DA239145 brain SLC25A37.a 79 to 643 2 to 567   capped   566/566
(100 %)
3 diff
(99.5 %id)
CN389167 embryonic stem cells, cell lines H1, H7, andH9 SLC25A37.a 79 to 611 1 to 533   tiling clone,   533/533
(100 %)
2 diff
(99.7 %id)
DA948853 Spleen SLC25A37.a 79 to 638 2 to 562   capped   561/561
(100 %)
2 diff
(99.7 %id)
DA042708 bladder SLC25A37.a 92 to 647 2 to 558   capped   557/557
(100 %)
4 diff
(99.3 %id)
CN389169 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 SLC25A37.a 103 to 353 1 to 253       253/253
(100 %)
2 diff
(99.3 %id)
BM563449 astrocytoma grade IV, cell line, brain SLC25A37.a 106 to 968 1 to 891       891/1034
(86 %)
42 diff
(96.0 %id)
BC132799 Brain, cerebellum, PCR rescued clones SLC25A37.a 136 to 1481 1 to 1347 exact tiling clone,   1347/1347
(100 %)
2 diff
(99.9 %id)
BC132801 Brain, cerebellum, PCR rescued clones SLC25A37.a 136 to 1481 1 to 1347 exact     1347/1347
(100 %)
2 diff
(99.9 %id)
TI_1752771076   SLC25A37.a 136 to 950 245 to 1056     Submitted on the opposite strand 812/1244
(65 %)
13 diff
(99.0 %id)
TI_1752769842   SLC25A37.a 136 to 1223 53 to 1131       1079/1283
(84 %)
23 diff
(98.3 %id)
TI_1752770206   SLC25A37.a 136 to 1061 244 to 1153     Submitted on the opposite strand 910/1258
(72 %)
34 diff
(97.3 %id)
BG777404 adenocarcinoma, Prostate SLC25A37.a 161 to 961 1 to 799       799/803
(99 %)
12 diff
(98.6 %id)
DA838268 placenta SLC25A37.a 162 to 639 2 to 479   capped   478/478
(100 %)
0 diff
(100 %id)
AF223466 hypothalamus SLC25A37.a 164 to 1572 1 to 1409 A296P G297A Y298T F299S G301A ... tiling clone, AAA Possibly primed on the genome, locally A rich (45/45 A in genome downstream of last aligned base) 1409/1409
(100 %)
6 diff
(99.6 %id)
CD628084   SLC25A37.a 165 to 520 370 to 15       356/371
(95 %)
4 diff
(99.0 %id)
BM926580 pooled lung and spleen SLC25A37.a 176 to 951 20 to 795       776/795
(97 %)
6 diff
(99.3 %id)
DA700985   SLC25A37.a 181 to 639 2 to 460   capped   459/459
(100 %)
0 diff
(100 %id)
BI831750 brain, medulla SLC25A37.a 197 to 945 1 to 747       747/750
(99 %)
7 diff
(99.1 %id)
TI_57175673   SLC25A37.a 197 to 952 64 to 816       753/879
(85 %)
14 diff
(98.5 %id)
DB448713 testis SLC25A37.a 235 to 677 1 to 443       443/443
(100 %)
3 diff
(99.4 %id)
AI133696 Liver SLC25A37.a 265 to 951 1 to 683       683/684
(99 %)
8 diff
(98.9 %id)
TI_1752769858   SLC25A37.a 297 to 1481 1245 to 72       1174/1313
(89 %)
16 diff
(98.8 %id)
AI650467 pooled germ cell tumors SLC25A37.a 310 to 415 106 to 1       106/106
(100 %)
0 diff
(100 %id)
AI951533 fibrotheoma, ovary SLC25A37.a 327 to 806 484 to 1       484/486
(99 %)
24 diff
(95.1 %id)
AI630395 blood SLC25A37.a 426 to 727 302 to 1       302/309
(97 %)
0 diff
(100 %id)
AV724895 hypothalamus SLC25A37.a 472 to 874 1 to 394       394/394
(100 %)
4 diff
(99.0 %id)
AI830053 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) SLC25A37.a 554 to 959 406 to 1       406/406
(100 %)
0 diff
(100 %id)
AI858078 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) SLC25A37.a 554 to 924 371 to 1       371/371
(100 %)
1 diff
(99.8 %id)
AI858083 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) SLC25A37.a 554 to 959 406 to 1       406/406
(100 %)
1 diff
(99.8 %id)
AI925217 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) SLC25A37.a 554 to 924 371 to 1       371/371
(100 %)
0 diff
(100 %id)
TI_1752770202   SLC25A37.a 619 to 1482 8 to 871       864/1251
(69 %)
8 diff
(99.4 %id)
AA683337   SLC25A37.a 646 to 927 282 to 1       282/282
(100 %)
2 diff
(99.3 %id)
AI088971 pooled SLC25A37.a 646 to 934 289 to 1       289/289
(100 %)
2 diff
(99.4 %id)
AI201887 Prostate SLC25A37.a 667 to 941 275 to 1       275/275
(100 %)
0 diff
(100 %id)
BM549642 leukocyte SLC25A37.a 690 to 950 1 to 261       261/261
(100 %)
0 diff
(100 %id)
BJ993086 hepatoblastoma SLC25A37.a 1099 to 1536 440 to 1   tiling clone,   440/440
(100 %)
1 diff
(99.8 %id)
BU166030 melanotic melanoma, skin SLC25A37.b 1 to 869 1 to 874   tiling clone,   874/874
(100 %)
10 diff
(98.9 %id)
BQ934885 large cell carcinoma, lung SLC25A37.b 374 to 1327 1 to 951 A178X Q193X A224X G229A I230S ... tiling clone,   951/951
(100 %)
15 diff
(98.5 %id)
BM552840 brain, medulla SLC25A37.c 1 to 940 15 to 951   tiling clone,   939/955
(98 %)
19 diff
(98.1 %id)
TI_154127509   SLC25A37.c 699 to 1565 957 to 97   AAA Possibly primed on the genome, locally A rich (45/45 A in genome downstream of last aligned base) 861/1017
(84 %)
22 diff
(97.9 %id)
BY996145   SLC25A37.c 767 to 1428 13 to 673   tiling clone,   661/673
(98 %)
6 diff
(99.2 %id)
CD723868 eye, lacrimal gland SLC25A37.c 777 to 1374 1 to 598       598/598
(100 %)
0 diff
(100 %id)
AV708528 adrenal gland SLC25A37.c 795 to 1530 1 to 732       732/741
(98 %)
15 diff
(98.0 %id)
AW953822   SLC25A37.c 815 to 1363 1 to 550       550/551
(99 %)
3 diff
(99.5 %id)
AA369715 placenta SLC25A37.c 816 to 1102 1 to 285       285/285
(100 %)
2 diff
(99.3 %id)
TI_149315191   SLC25A37.c 818 to 1565 821 to 80   AAA Possibly primed on the genome, locally A rich (45/45 A in genome downstream of last aligned base) 742/978
(75 %)
41 diff
(95.9 %id)
FN129622 breast carcinoma SLC25A37.c 820 to 920 102 to 1     Submitted on the opposite strand 102/102
(100 %)
1 diff
(99.1 %id)
BQ181834 Knee, Osteoarthritic Cartilage SLC25A37.c 827 to 1583 757 to 1   tiling clone,   757/757
(100 %)
1 diff
(99.9 %id)
CA445336 Chondrosarcoma, Left Pubic Bone SLC25A37.c 834 to 1583 751 to 1       751/751
(100 %)
2 diff
(99.8 %id)
CA306158 Alveolar Macrophage, lung SLC25A37.c 834 to 1583 751 to 1       751/751
(100 %)
1 diff
(99.9 %id)
BM792434 Ascites, stomach SLC25A37.c 842 to 1347 1 to 506       506/506
(100 %)
0 diff
(100 %id)
BQ670802 epidermoid carcinoma, cell line, salivary gland SLC25A37.c 845 to 1516 1 to 673       673/939
(71 %)
19 diff
(98.0 %id)
TI_154041351   SLC25A37.c 846 to 1565 799 to 78   AAA Possibly primed on the genome, locally A rich (45/45 A in genome downstream of last aligned base) 722/975
(74 %)
2 diff
(99.8 %id)
CR743139   SLC25A37.c 847 to 1565 1 to 719   AAA Possibly primed on the genome, locally A rich (45/45 A in genome downstream of last aligned base) 719/719
(100 %)
2 diff
(99.8 %id)
BU657598 blood SLC25A37.c 848 to 1273 436 to 11     Submitted on the opposite strand 426/436
(97 %)
0 diff
(100 %id)
CN480138 Knee, Osteoarthritic Cartilage SLC25A37.c 858 to 1583 728 to 1       728/728
(100 %)
2 diff
(99.8 %id)
BU617678 Bone, Subchondral Bone SLC25A37.c 941 to 1583 644 to 1       644/644
(100 %)
3 diff
(99.6 %id)
BM271710 Pancreas, Purified pancreatic islet SLC25A37.c 944 to 1520 1 to 578     Submitted on the opposite strand 578/578
(100 %)
3 diff
(99.5 %id)
AA447775 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus SLC25A37.c 944 to 1581 1 to 645     Submitted on the opposite strand 645/654
(98 %)
54 diff
(91.8 %id)
BE669558 carcinoid, lung SLC25A37.c 944 to 1445 1 to 502     Submitted on the opposite strand 502/502
(100 %)
1 diff
(99.9 %id)
BG149200 carcinoid, lung SLC25A37.c 944 to 1446 1 to 504     Submitted on the opposite strand 504/504
(100 %)
3 diff
(99.5 %id)
BF447812 carcinoid, lung SLC25A37.c 944 to 1460 1 to 517     Submitted on the opposite strand 517/517
(100 %)
1 diff
(99.9 %id)
N90124 lung SLC25A37.c 945 to 1388 1 to 444     Submitted on the opposite strand 444/444
(100 %)
9 diff
(98.0 %id)
AA228012 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus SLC25A37.c 945 to 1382 1 to 438     Submitted on the opposite strand 438/438
(100 %)
4 diff
(99.1 %id)
AA459297 ovarian tumor, ovary SLC25A37.c 945 to 1427 1 to 483     Submitted on the opposite strand 483/483
(100 %)
2 diff
(99.6 %id)
AI027819 parathyroid gland, parathyroid tumor SLC25A37.c 945 to 1468 1 to 525     Submitted on the opposite strand 525/525
(100 %)
1 diff
(99.9 %id)
AI193143 lung SLC25A37.c 945 to 1470 1 to 527     Submitted on the opposite strand 527/527
(100 %)
5 diff
(99.1 %id)
AI203832 lung SLC25A37.c 945 to 1063 1 to 119     Submitted on the opposite strand 119/119
(100 %)
0 diff
(100 %id)
AI223053 pooled SLC25A37.c 945 to 1444 1 to 501     Submitted on the opposite strand 501/501
(100 %)
4 diff
(99.3 %id)
AI285946 pooled SLC25A37.c 945 to 1445 1 to 498     Submitted on the opposite strand 498/498
(100 %)
2 diff
(99.6 %id)
AI261492 adenocarcinoma, colon SLC25A37.c 945 to 1399 1 to 455     Submitted on the opposite strand 455/455
(100 %)
0 diff
(100 %id)
AI262021 adenocarcinoma, colon SLC25A37.c 945 to 1388 1 to 444     Submitted on the opposite strand 444/444
(100 %)
0 diff
(100 %id)
AI278176 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus SLC25A37.c 945 to 1384 1 to 441     Submitted on the opposite strand 441/441
(100 %)
1 diff
(99.8 %id)
AI215180 carcinoid, lung SLC25A37.c 945 to 1393 1 to 449     Submitted on the opposite strand 449/449
(100 %)
0 diff
(100 %id)
AI300376 carcinoid, lung SLC25A37.c 945 to 1130 1 to 186     Submitted on the opposite strand 186/186
(100 %)
0 diff
(100 %id)
AI367638   SLC25A37.c 945 to 1428 1 to 485     Submitted on the opposite strand 485/485
(100 %)
3 diff
(99.4 %id)
AI342451 lung SLC25A37.c 945 to 1428 1 to 485     Submitted on the opposite strand 485/485
(100 %)
1 diff
(99.8 %id)
AI493737 B-cell, chronic lymphotic leukemia SLC25A37.c 945 to 1417 1 to 475     Submitted on the opposite strand 475/475
(100 %)
2 diff
(99.6 %id)
AI382793 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus SLC25A37.c 945 to 1261 1 to 316     Submitted on the opposite strand 316/316
(100 %)
3 diff
(99.1 %id)
AI392728 B-cell, chronic lymphotic leukemia SLC25A37.c 945 to 1394 1 to 451     Submitted on the opposite strand 451/451
(100 %)
1 diff
(99.8 %id)
AI400741 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus SLC25A37.c 945 to 1401 1 to 457     Submitted on the opposite strand 457/457
(100 %)
0 diff
(100 %id)
AI871594 carcinoid, lung SLC25A37.c 945 to 1460 1 to 516     Submitted on the opposite strand 516/516
(100 %)
1 diff
(99.9 %id)
AW003234 pooled germ cell tumors SLC25A37.c 945 to 1468 1 to 525     Submitted on the opposite strand 525/525
(100 %)
4 diff
(99.3 %id)
AW043650 pooled SLC25A37.c 945 to 1428 1 to 485     Submitted on the opposite strand 485/485
(100 %)
1 diff
(99.8 %id)
AW629315 pooled SLC25A37.c 945 to 1424 1 to 481     Submitted on the opposite strand 481/481
(100 %)
2 diff
(99.6 %id)
BE551855 pooled germ cell tumors SLC25A37.c 945 to 1460 1 to 516     Submitted on the opposite strand 516/516
(100 %)
1 diff
(99.9 %id)
BE675476 B-cell, chronic lymphotic leukemia SLC25A37.c 945 to 1469 1 to 528     Submitted on the opposite strand 528/528
(100 %)
2 diff
(99.7 %id)
BE677761 pooled SLC25A37.c 945 to 1511 1 to 569     Submitted on the opposite strand 569/569
(100 %)
2 diff
(99.7 %id)
BF591137 colon, colon tumor, RER+ SLC25A37.c 945 to 1469 1 to 527     Submitted on the opposite strand 527/527
(100 %)
1 diff
(99.9 %id)
BF115226 fibrotheoma, ovary SLC25A37.c 945 to 1460 1 to 516     Submitted on the opposite strand 516/516
(100 %)
3 diff
(99.5 %id)
BF115270 fibrotheoma, ovary SLC25A37.c 945 to 1452 1 to 509     Submitted on the opposite strand 509/509
(100 %)
4 diff
(99.3 %id)
TI_157611787   SLC25A37.c 945 to 1565 60 to 684   AAA Submitted on the opposite strand 625/684
(91 %)
6 diff
(99.2 %id)
AW016927   SLC25A37.c 946 to 1365 1 to 420     Submitted on the opposite strand 420/420
(100 %)
1 diff
(99.8 %id)
AA479942 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus SLC25A37.c 948 to 1366 1 to 418     Submitted on the opposite strand 418/418
(100 %)
7 diff
(98.4 %id)
AI174910 Liver SLC25A37.c 953 to 1565 1 to 615   AAA Possibly primed on the genome, locally A rich (45/45 A in genome downstream of last aligned base) 615/615
(100 %)
2 diff
(99.7 %id)
CB048958 Prostate SLC25A37.c 953 to 1565 1 to 613   AAA Submitted on the opposite strand 613/613
(100 %)
0 diff
(100 %id)
CB048959 Prostate SLC25A37.c 953 to 1565 648 to 36   AAA Submitted on the opposite strand 613/613
(100 %)
0 diff
(100 %id)
AI207643 Liver SLC25A37.c 954 to 1556 605 to 1       605/607
(99 %)
3 diff
(99.6 %id)
AI743950 pooled SLC25A37.c 954 to 1506 1 to 555     Submitted on the opposite strand 555/555
(100 %)
2 diff
(99.7 %id)
BF062215 pooled germ cell tumors SLC25A37.c 954 to 1316 1 to 363     Submitted on the opposite strand 363/363
(100 %)
1 diff
(99.8 %id)
BF591907 Kidney SLC25A37.c 954 to 1307 1 to 354     Submitted on the opposite strand 354/354
(100 %)
3 diff
(99.2 %id)
AA057245.
matches multiple genes
eye, retina SLC25A37.c 957 to 1558 589 to 1     Submitted on the opposite strand, also hits gene RNF144A 589/646
(91 %)
17 diff
(97.4 %id)
AI092840 heart SLC25A37.c 958 to 1370 1 to 414     Submitted on the opposite strand 414/414
(100 %)
2 diff
(99.6 %id)
AI580179 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus SLC25A37.c 958 to 1446 1 to 490     Submitted on the opposite strand 490/490
(100 %)
3 diff
(99.4 %id)
AI589902 anaplastic oligodendroglioma, brain SLC25A37.c 958 to 1502 1 to 545     Submitted on the opposite strand 545/545
(100 %)
0 diff
(100 %id)
AI636074 Kidney SLC25A37.c 958 to 1467 1 to 510     Submitted on the opposite strand 510/510
(100 %)
4 diff
(99.3 %id)
AI765135 colon, colon tumor, RER+ SLC25A37.c 959 to 1445 1 to 487     Submitted on the opposite strand 487/487
(100 %)
0 diff
(100 %id)
AI204646 heart SLC25A37.c 963 to 1348 1 to 386     Submitted on the opposite strand 386/386
(100 %)
2 diff
(99.5 %id)
AI141102 lung SLC25A37.c 963 to 1405 1 to 445     Submitted on the opposite strand 445/445
(100 %)
1 diff
(99.8 %id)
AI246680 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus SLC25A37.c 963 to 1369 1 to 408     Submitted on the opposite strand 408/408
(100 %)
1 diff
(99.8 %id)
AI273440 adenocarcinoma, colon SLC25A37.c 963 to 1426 1 to 464     Submitted on the opposite strand 464/464
(100 %)
0 diff
(100 %id)
AI351268 lung SLC25A37.c 963 to 1282 1 to 321     Submitted on the opposite strand 321/321
(100 %)
1 diff
(99.7 %id)
AI347510 colon, colon tumor, RER+ SLC25A37.c 963 to 1403 1 to 443     Submitted on the opposite strand 443/443
(100 %)
1 diff
(99.8 %id)
AI376357   SLC25A37.c 963 to 1404 1 to 443     Submitted on the opposite strand 443/443
(100 %)
1 diff
(99.8 %id)
AI439573 B-cell, chronic lymphotic leukemia SLC25A37.c 963 to 1405 1 to 445     Submitted on the opposite strand 445/445
(100 %)
2 diff
(99.6 %id)
AI439592 B-cell, chronic lymphotic leukemia SLC25A37.c 963 to 1401 1 to 441     Submitted on the opposite strand 441/441
(100 %)
3 diff
(99.4 %id)
AI399836 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus SLC25A37.c 963 to 1369 1 to 408     Submitted on the opposite strand 408/408
(100 %)
1 diff
(99.8 %id)
AI914209 carcinoid, lung SLC25A37.c 963 to 1380 1 to 418     Submitted on the opposite strand 418/418
(100 %)
2 diff
(99.6 %id)
AW197214 pooled germ cell tumors SLC25A37.c 963 to 1428 1 to 466     Submitted on the opposite strand 466/466
(100 %)
1 diff
(99.8 %id)
AW614430 Kidney SLC25A37.c 963 to 1422 1 to 460     Submitted on the opposite strand 460/460
(100 %)
0 diff
(100 %id)
BE348795 carcinoid, lung SLC25A37.c 964 to 1459 1 to 496     Submitted on the opposite strand 496/496
(100 %)
0 diff
(100 %id)
BQ773673 Chondrosarcoma Grade II, Left Pelvis SLC25A37.c 967 to 1583 618 to 1       618/618
(100 %)
1 diff
(99.9 %id)
CA417183 Chondrosarcoma Cell line SLC25A37.c 967 to 1583 618 to 1       618/618
(100 %)
2 diff
(99.7 %id)
CA421627 Bone, Enchondroma cell line SLC25A37.c 967 to 1583 617 to 1       617/617
(100 %)
2 diff
(99.7 %id)
CK824923 Pancreas, Purified pancreatic islet SLC25A37.c 970 to 1241 1 to 273   fully sequenced,   273/273
(100 %)
0 diff
(100 %id)
BF000591 colon, colon tumor, RER+ SLC25A37.c 971 to 1460 1 to 490     Submitted on the opposite strand 490/490
(100 %)
1 diff
(99.8 %id)
AI346284 adenocarcinoma, colon SLC25A37.c 972 to 1370 1 to 400     Submitted on the opposite strand 400/400
(100 %)
2 diff
(99.5 %id)
AI128538 placenta SLC25A37.c 978 to 1434 1 to 457     Submitted on the opposite strand 457/457
(100 %)
1 diff
(99.8 %id)
AI694244 colon SLC25A37.c 978 to 1429 1 to 453     Submitted on the opposite strand 453/453
(100 %)
3 diff
(99.4 %id)
AI675107 Prostate SLC25A37.c 981 to 1467 1 to 487     Submitted on the opposite strand 487/487
(100 %)
2 diff
(99.6 %id)
AA313800 colon SLC25A37.c 987 to 1398 1 to 413       413/413
(100 %)
2 diff
(99.6 %id)
AI912117 carcinoid, lung SLC25A37.c 987 to 1393 1 to 407     Submitted on the opposite strand 407/407
(100 %)
0 diff
(100 %id)
AI694653 carcinoid, lung SLC25A37.c 987 to 1395 1 to 409     Submitted on the opposite strand 409/409
(100 %)
0 diff
(100 %id)
BE221818 Kidney SLC25A37.c 992 to 1563 1 to 572     Submitted on the opposite strand 572/572
(100 %)
0 diff
(100 %id)
BM982902 lung, Primary Lung Cystic Fibrosis EpithelialCells SLC25A37.c 992 to 1640 663 to 19   AAA Possibly primed on the genome, locally A rich (45/45 A in genome downstream of last aligned base) 645/645
(100 %)
10 diff
(98.5 %id)
BE550036 carcinoid, lung SLC25A37.c 997 to 1522 1 to 526     Submitted on the opposite strand 526/526
(100 %)
0 diff
(100 %id)
R67005 placenta SLC25A37.c 1004 to 1383 1 to 391     Submitted on the opposite strand 391/391
(100 %)
18 diff
(95.4 %id)
AA481390 germinal center B cell SLC25A37.c 1015 to 1370 1 to 356     Submitted on the opposite strand 356/356
(100 %)
3 diff
(99.2 %id)
AA465507 germinal center B cell SLC25A37.c 1032 to 1559 526 to 1     Submitted on the opposite strand 526/526
(100 %)
14 diff
(97.4 %id)
BG236178 blood, lymphocyte SLC25A37.c 1033 to 1566 536 to 1       536/537
(99 %)
2 diff
(99.7 %id)
AI379355 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus SLC25A37.c 1034 to 1184 1 to 151     Submitted on the opposite strand 151/151
(100 %)
0 diff
(100 %id)
AA832397 germinal center B cell SLC25A37.c 1042 to 1172 1 to 131     Submitted on the opposite strand 131/131
(100 %)
0 diff
(100 %id)
AA453707 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus SLC25A37.c 1044 to 1559 516 to 1     Submitted on the opposite strand 516/522
(98 %)
8 diff
(98.5 %id)
AW968116   SLC25A37.c 1052 to 1560 567 to 59   AAA Submitted on the opposite strand 509/514
(99 %)
0 diff
(100 %id)
BM272030 Pancreas, Purified pancreatic islet SLC25A37.c 1059 to 1560 563 to 61   AAA Submitted on the opposite strand 503/508
(99 %)
0 diff
(100 %id)
H21546 breast SLC25A37.c 1064 to 1181 1 to 118     Submitted on the opposite strand 118/118
(100 %)
0 diff
(100 %id)
AA459528 ovarian tumor, ovary SLC25A37.c 1084 to 1583 498 to 1     Submitted on the opposite strand 498/499
(99 %)
6 diff
(98.8 %id)
AL597352   SLC25A37.c 1091 to 1572 1 to 480       480/480
(100 %)
4 diff
(99.2 %id)
BG058812 blood, lymphocyte SLC25A37.c 1093 to 1565 476 to 1       476/476
(100 %)
1 diff
(99.8 %id)
BQ016028 lung, Metastatic Chondrosarcoma SLC25A37.c 1096 to 1583 490 to 1       490/490
(100 %)
4 diff
(99.2 %id)
CN479267 lung, Primary Lung Cystic Fibrosis EpithelialCells SLC25A37.c 1096 to 1583 493 to 1       493/493
(100 %)
4 diff
(99.2 %id)
AA478846 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus SLC25A37.c 1101 to 1559 458 to 1     Submitted on the opposite strand 458/458
(100 %)
5 diff
(99.0 %id)
AI719270 aorta SLC25A37.c 1107 to 1565 460 to 1       460/460
(100 %)
1 diff
(99.8 %id)
BP393378 pancreatic islet SLC25A37.c 1128 to 1565 1 to 439     Submitted on the opposite strand 439/439
(100 %)
3 diff
(99.4 %id)
AA477065 ovarian tumor, ovary SLC25A37.c 1133 to 1583 450 to 1     Submitted on the opposite strand 450/450
(100 %)
3 diff
(99.4 %id)
H66660 liver and spleen SLC25A37.c 1144 to 1355 1 to 217   fully sequenced,   217/217
(100 %)
2 diff
(99.1 %id)
H51859 liver and spleen SLC25A37.c 1166 to 1566 408 to 1     Submitted on the opposite strand 408/434
(94 %)
10 diff
(97.7 %id)
H92164 eye, retina SLC25A37.c 1169 to 1554 406 to 12     Submitted on the opposite strand 395/406
(97 %)
0 diff
(100 %id)
AA342837 Spleen SLC25A37.c 1170 to 1565 396 to 1       396/396
(100 %)
0 diff
(100 %id)
AW604708 colon SLC25A37.c 1172 to 1338 174 to 5       170/181
(93 %)
0 diff
(100 %id)
AI521889 Kidney SLC25A37.c 1173 to 1568 397 to 1       397/397
(100 %)
1 diff
(99.8 %id)
BM709912 eye, Retina Foveal and Macular SLC25A37.c 1179 to 1561 1 to 385   fully sequenced,   385/385
(100 %)
4 diff
(99.0 %id)
CK824922 Pancreas, Purified pancreatic islet SLC25A37.c 1211 to 1568 359 to 1   fully sequenced,   359/359
(100 %)
3 diff
(99.2 %id)
H63196 liver and spleen SLC25A37.c 1228 to 1558 335 to 1     Submitted on the opposite strand 335/336
(99 %)
11 diff
(96.8 %id)
H88106 eye, retina SLC25A37.c 1229 to 1563 340 to 1     Submitted on the opposite strand 340/342
(99 %)
10 diff
(97.1 %id)
CB140412 Liver SLC25A37.c 1229 to 1570 1 to 342       342/342
(100 %)
0 diff
(100 %id)
BU736681 eye, Retina Foveal and Macular SLC25A37.c 1238 to 1583 348 to 1   fully sequenced,   348/348
(100 %)
1 diff
(99.8 %id)
H49847 brain SLC25A37.c 1245 to 1575 343 to 1     Submitted on the opposite strand 343/343
(100 %)
15 diff
(95.7 %id)
H73791 liver and spleen SLC25A37.c 1261 to 1566 306 to 1     Submitted on the opposite strand 306/306
(100 %)
4 diff
(98.7 %id)
CD368054 Alveolar Macrophage, lung SLC25A37.c 1261 to 1910 663 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (45/45 A in genome downstream of last aligned base) 645/645
(100 %)
6 diff
(99.1 %id)
AA419172 ovarian tumor, ovary SLC25A37.c 1290 to 1559 269 to 1     Submitted on the opposite strand 269/269
(100 %)
4 diff
(98.6 %id)
R68314 placenta SLC25A37.c 1298 to 1566 271 to 1     Submitted on the opposite strand 271/282
(96 %)
3 diff
(99.0 %id)
H66661 liver and spleen SLC25A37.c 1325 to 1565 244 to 1   fully sequenced,   244/244
(100 %)
3 diff
(98.8 %id)
W16743 lung SLC25A37.c 1380 to 1566 187 to 1     Submitted on the opposite strand 187/187
(100 %)
0 diff
(100 %id)
H73778 liver and spleen SLC25A37.c 1406 to 1566 161 to 1     Submitted on the opposite strand 161/161
(100 %)
0 diff
(100 %id)
BF718357 epidermis, skin SLC25A37.c 1434 to 1562 129 to 1       129/129
(100 %)
0 diff
(100 %id)
EC494398 Prostate SLC25A37.c 1436 to 1536 99 to 1       99/103
(96 %)
2 diff
(98.1 %id)
EC544059 Prostate SLC25A37.c 1466 to 1561 105 to 8       98/105
(93 %)
0 diff
(100 %id)
DB498986 hypothalamus SLC25A37.c 1538 to 1911 1 to 387       387/422
(91 %)
15 diff
(96.5 %id)
H40450 liver and spleen SLC25A37.c 1614 to 1909 301 to 5       297/301
(98 %)
0 diff
(100 %id)
CD515521 White Matter SLC25A37.d-u -9 to 680 1 to 703 V202L R203S A204G G205W W206L ... tiling clone,   703/966
(72 %)
24 diff
(97.6 %id)
BX448842 fetal liver, Liver SLC25A37.d-u 1 to 505 8 to 513   tiling clone,   513/518
(99 %)
9 diff
(98.3 %id)
DA799112 brain SLC25A37.e-u 1 to 542 2 to 544   tiling clone, capped   543/543
(100 %)
2 diff
(99.7 %id)
CB163524 Liver SLC25A37.e-u 180 to 732 553 to 1     Submitted on the opposite strand 553/553
(100 %)
0 diff
(100 %id)
CA867474 Pancreas, Purified pancreatic islet SLC25A37.e-u 186 to 634 4 to 452   fully sequenced,   449/452
(99 %)
5 diff
(98.9 %id)
TI_154111212   SLC25A37.e-u 217 to 1066 888 to 49   tiling clone,   840/892
(94 %)
0 diff
(100 %id)
AA358568 lung SLC25A37.e-u 232 to 579 1 to 350       350/350
(100 %)
7 diff
(98.0 %id)
BP224446 colon mucosa SLC25A37.e-u 241 to 795 1 to 562       562/562
(100 %)
14 diff
(97.6 %id)
BP224266 colon mucosa SLC25A37.e-u 242 to 561 1 to 321       321/326
(98 %)
4 diff
(98.8 %id)
BM989022 Bone, Subchondral Bone SLC25A37.e-u 342 to 1057 717 to 1   tiling clone,   717/717
(100 %)
1 diff
(99.9 %id)
CA431747 Bone, Subchondral Bone SLC25A37.e-u 366 to 1057 693 to 1       693/693
(100 %)
1 diff
(99.9 %id)
CA426109 Bone, Subchondral Bone SLC25A37.e-u 368 to 1057 689 to 1       689/691
(99 %)
7 diff
(99.0 %id)
T51807 fetal spleen, Spleen SLC25A37.e-u 381 to 700 1 to 327   fully sequenced,   327/327
(100 %)
14 diff
(95.8 %id)
CV375680 nervous_normal SLC25A37.e-u 412 to 725 1 to 315       315/315
(100 %)
7 diff
(97.8 %id)
CB115221 Liver SLC25A37.e-u 443 to 1032 590 to 1     Submitted on the opposite strand 590/590
(100 %)
2 diff
(99.7 %id)
DB381926 thyroid gland SLC25A37.e-u 495 to 1039 544 to 1       544/544
(100 %)
14 diff
(97.5 %id)
AW780209 colon, moderately-differentiated adenocarcinoma SLC25A37.e-u 529 to 1040 512 to 1       512/512
(100 %)
1 diff
(99.9 %id)
CN372055 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 SLC25A37.e-u 539 to 1043 1 to 505       505/505
(100 %)
5 diff
(99.1 %id)
H80182 liver and spleen SLC25A37.e-u 567 to 998 438 to 1     Submitted on the opposite strand 438/440
(99 %)
11 diff
(97.5 %id)
DB564663 hypothalamus SLC25A37.e-u 578 to 1039 1 to 462     Submitted on the opposite strand 462/462
(100 %)
3 diff
(99.4 %id)
N99578 liver and spleen SLC25A37.e-u 580 to 1039 469 to 1     Submitted on the opposite strand 469/471
(99 %)
14 diff
(97.1 %id)
R92924 liver and spleen SLC25A37.e-u 594 to 1039 448 to 1     Submitted on the opposite strand 448/448
(100 %)
8 diff
(98.3 %id)
CA943489 Pancreas, Purified pancreatic islet SLC25A37.e-u 604 to 1039 436 to 1   fully sequenced,   436/436
(100 %)
1 diff
(99.8 %id)
DB560429 hypothalamus SLC25A37.e-u 608 to 1039 1 to 433     Submitted on the opposite strand 433/433
(100 %)
4 diff
(99.1 %id)
DA323607 hippocampus SLC25A37.e-u 617 to 1161 2 to 546   to resequence, capped   545/545
(100 %)
6 diff
(98.9 %id)
T51649 fetal spleen, Spleen SLC25A37.e-u 691 to 1007 325 to 1   fully sequenced,   325/325
(100 %)
7 diff
(97.9 %id)
N72824 liver and spleen SLC25A37.e-u 835 to 1033 199 to 1     Submitted on the opposite strand 199/199
(100 %)
1 diff
(99.5 %id)
DB145105 thymus SLC25A37.e-u 904 to 1232 2 to 328   tiling clone, capped   327/327
(100 %)
2 diff
(99.4 %id)
AK093931 trachea SLC25A37.e-u 1619 to 4293 1 to 2677 exact tiling clone, available from FLJ,   2677/2677
(100 %)
2 diff
(100.0 %id)
DB204635 trachea SLC25A37.e-u 1620 to 2199 2 to 582   capped   581/581
(100 %)
1 diff
(99.9 %id)
CN411483 embryonic stem cells, cell lines H1, H7, andH9 SLC25A37.e-u 1655 to 2274 1 to 615       615/615
(100 %)
7 diff
(98.9 %id)
CD629349   SLC25A37.e-u 1731 to 2438 9 to 709       701/709
(98 %)
14 diff
(98.1 %id)
CD629350   SLC25A37.e-u 1731 to 2491 9 to 764       756/767
(98 %)
6 diff
(99.3 %id)
DA254637 caudate nucleus SLC25A37.e-u 1769 to 2335 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
BC069168 Synthetic constructs SLC25A37.e-u 2048 to 2593 5 to 550   available from MGC, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 546/606
(90 %)
6 diff
(99.1 %id)
BC033834 Bone, osteosarcoma SLC25A37.e-u 2055 to 2593 12 to 551   available from MGC, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 540/596
(90 %)
2 diff
(99.7 %id)
BG026575 Bone, osteosarcoma, cell line SLC25A37.e-u 2055 to 2592 1 to 535   available from MGC,   535/581
(92 %)
6 diff
(99.0 %id)
DA569129 whole embryo, mainly head SLC25A37.e-u 2085 to 2754 2 to 668   capped   667/667
(100 %)
4 diff
(99.5 %id)
AI065035 Liver SLC25A37.e-u 2194 to 2515 1 to 322       322/322
(100 %)
0 diff
(100 %id)
AF116640 Liver SLC25A37.e-u 2203 to 3672 1 to 1470       1470/1470
(100 %)
3 diff
(99.8 %id)
AI132998 Liver SLC25A37.e-u 2203 to 2516 1 to 314       314/315
(99 %)
2 diff
(99.4 %id)
AI110825 Liver SLC25A37.e-u 2204 to 2767 1 to 565       565/565
(100 %)
1 diff
(99.9 %id)
AF075324 Liver SLC25A37.e-u 2204 to 2767 1 to 565       565/565
(100 %)
1 diff
(99.9 %id)
CN268575 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells SLC25A37.e-u 2251 to 2611 1 to 361       361/361
(100 %)
6 diff
(98.4 %id)
BE841007 stomach_normal SLC25A37.e-u 2263 to 2675 1 to 414       414/414
(100 %)
6 diff
(98.6 %id)
BF683630 leiomyosarcoma cell line, uterus SLC25A37.e-u 2271 to 2965 1 to 695       695/696
(99 %)
32 diff
(95.5 %id)
CF454750 peripheral nervous system SLC25A37.e-u 2326 to 2990 34 to 698       665/699
(95 %)
8 diff
(98.9 %id)
BG180807 adenocarcinoma, cell line, Prostate SLC25A37.e-u 2386 to 3159 1 to 752       752/920
(81 %)
26 diff
(97.2 %id)
AF116693 Liver SLC25A37.e-u 2513 to 3672 140 to 1299   tiling clone,   1160/1299
(89 %)
6 diff
(99.6 %id)
AI133598 Liver SLC25A37.e-u 2513 to 3017 140 to 644       505/647
(78 %)
1 diff
(99.9 %id)
CA454460   SLC25A37.e-u 2523 to 3375 1 to 867       867/871
(99 %)
20 diff
(97.8 %id)
DN998335 bone marrow SLC25A37.e-u 2545 to 3146 2 to 603       602/603
(99 %)
6 diff
(99.1 %id)
CB053843 leiomyosarcoma, soft tissue SLC25A37.e-u 2549 to 3024 10 to 485   fully sequenced,   476/485
(98 %)
1 diff
(99.8 %id)
DB119524 thymus SLC25A37.e-u 2573 to 3109 2 to 538   capped   537/537
(100 %)
0 diff
(100 %id)
BQ899395 sciatic nerve SLC25A37.e-u 2582 to 3383 1 to 810       810/896
(90 %)
17 diff
(98.2 %id)
BX643401   SLC25A37.e-u 2674 to 3304 1 to 631       631/631
(100 %)
1 diff
(99.9 %id)
R86023 breast SLC25A37.e-u 2705 to 3075 1 to 380       380/380
(100 %)
9 diff
(97.7 %id)
BX280134 anaplastic oligodendroglioma, brain SLC25A37.e-u 2811 to 3294 1 to 484       484/484
(100 %)
0 diff
(100 %id)
AA031271 uterus SLC25A37.e-u 2904 to 3221 1 to 320   fully sequenced,   320/320
(100 %)
7 diff
(97.9 %id)
AA046778 uterus SLC25A37.e-u 2904 to 3198 1 to 298       298/321
(92 %)
7 diff
(97.9 %id)
CB594722 Blood, promyelocytic leukemia SLC25A37.e-u 2926 to 3278 1 to 361       361/632
(57 %)
10 diff
(98.5 %id)
CB053842 leiomyosarcoma, soft tissue SLC25A37.e-u 2994 to 3672 678 to 1   fully sequenced,   678/678
(100 %)
1 diff
(99.9 %id)
R09336 liver and spleen SLC25A37.e-u 3042 to 3243 1 to 203       203/206
(98 %)
2 diff
(99.1 %id)
AA814408 germinal center B cell SLC25A37.e-u 3069 to 3608 538 to 1       538/538
(100 %)
5 diff
(99.1 %id)
BF766831 colon_est SLC25A37.e-u 3084 to 3246 11 to 166       156/175
(89 %)
9 diff
(94.9 %id)
BM705362 eye, RPE and Choroid SLC25A37.e-u 3101 to 3556 1 to 455       455/455
(100 %)
1 diff
(99.8 %id)
TI_151713515   SLC25A37.e-u 3101 to 3680 663 to 85       579/799
(72 %)
0 diff
(100 %id)
TI_151750260   SLC25A37.e-u 3101 to 3680 628 to 49       580/1243
(46 %)
0 diff
(100 %id)
BG542808 lung SLC25A37.e-u 3146 to 3776 1 to 620       620/621
(99 %)
28 diff
(95.5 %id)
AW005811 anaplastic oligodendroglioma, brain SLC25A37.e-u 3155 to 3680 526 to 1       526/526
(100 %)
0 diff
(100 %id)
BF446051 breast, invasive ductal carcinoma, 3 pooled samples SLC25A37.e-u 3156 to 3680 547 to 23       525/547
(95 %)
0 diff
(100 %id)
H92824 pineal gland SLC25A37.e-u 3183 to 3627 443 to 1       443/443
(100 %)
9 diff
(98.0 %id)
AA031272 uterus SLC25A37.e-u 3191 to 3680 495 to 1   fully sequenced,   495/495
(100 %)
19 diff
(96.2 %id)
AI076495   SLC25A37.e-u 3192 to 3619 428 to 1       428/428
(100 %)
1 diff
(99.8 %id)
AI127450 heart SLC25A37.e-u 3192 to 3662 471 to 1       471/471
(100 %)
1 diff
(99.8 %id)
AI073965 B-cell, chronic lymphotic leukemia SLC25A37.e-u 3194 to 3680 488 to 1       488/488
(100 %)
2 diff
(99.6 %id)
AA760714 germinal center B cell SLC25A37.e-u 3195 to 3609 414 to 1       414/414
(100 %)
5 diff
(98.8 %id)
AW151526 poorly differentiated adenocarcinoma withsignet ring cell features, stomach SLC25A37.e-u 3196 to 3680 486 to 2       485/486
(99 %)
0 diff
(100 %id)
AI127197 heart SLC25A37.e-u 3197 to 3671 475 to 1       475/475
(100 %)
6 diff
(98.8 %id)
AA649138 germinal center B cell SLC25A37.e-u 3202 to 3606 401 to 1       401/401
(100 %)
12 diff
(97.1 %id)
R85982 breast SLC25A37.e-u 3208 to 3549 343 to 1       343/372
(92 %)
15 diff
(96.0 %id)
AA927931 pooled SLC25A37.e-u 3208 to 3593 440 to 56       385/440
(87 %)
0 diff
(100 %id)
AA736462 germinal center B cell SLC25A37.e-u 3234 to 3591 356 to 2       355/356
(99 %)
0 diff
(100 %id)
AI167780 parathyroid gland, parathyroid tumor SLC25A37.e-u 3234 to 3680 447 to 1       447/447
(100 %)
0 diff
(100 %id)
AA836045 germinal center B cell SLC25A37.e-u 3259 to 3387 128 to 1       128/128
(100 %)
1 diff
(99.3 %id)
AA766652 germinal center B cell SLC25A37.e-u 3262 to 3599 327 to 1       327/352
(92 %)
12 diff
(96.6 %id)
AI217406 pooled SLC25A37.e-u 3279 to 3680 402 to 1       402/402
(100 %)
0 diff
(100 %id)
H27518 breast SLC25A37.e-u 3291 to 3654 379 to 3       377/379
(99 %)
0 diff
(100 %id)
AA725405 parathyroid gland, parathyroid tumor SLC25A37.e-u 3292 to 3648 357 to 1       357/357
(100 %)
2 diff
(99.5 %id)
AA761150 germinal center B cell SLC25A37.e-u 3292 to 3608 316 to 1       316/316
(100 %)
1 diff
(99.7 %id)
AA935615 pooled SLC25A37.e-u 3292 to 3648 357 to 1       357/357
(100 %)
0 diff
(100 %id)
AA916572 carcinoid, lung SLC25A37.e-u 3308 to 3680 369 to 1       369/369
(100 %)
9 diff
(97.6 %id)
AA876025 colon, colon tumor RER+ SLC25A37.e-u 3335 to 3648 313 to 1       313/313
(100 %)
1 diff
(99.7 %id)
AI220833 placenta SLC25A37.e-u 3340 to 3645 306 to 1       306/306
(100 %)
0 diff
(100 %id)
TI_154110617   SLC25A37.e-u 3349 to 4293 1013 to 76 R14X V16C W17E R18X T19P ... tiling clone, AAA Possibly primed on the genome, locally A rich (45/45 A in genome downstream of last aligned base) 938/980
(95 %)
14 diff
(98.6 %id)
TI_154101970   SLC25A37.e-u 3362 to 4293 985 to 59 W17* tiling clone, AAA Possibly primed on the genome, locally A rich (45/45 A in genome downstream of last aligned base) 927/939
(98 %)
16 diff
(98.3 %id)
R46667 breast SLC25A37.e-u 3370 to 3635 269 to 1       269/312
(86 %)
13 diff
(95.9 %id)
AI766713 B-cell, chronic lymphotic leukemia SLC25A37.e-u 3398 to 3653 256 to 1       256/256
(100 %)
0 diff
(100 %id)
AA046639 uterus SLC25A37.e-u 3401 to 3676 278 to 5       274/285
(96 %)
0 diff
(100 %id)
DB355728 whole embryo, mainly head SLC25A37.e-u 3740 to 4293 563 to 1       563/565
(99 %)
15 diff
(97.4 %id)
DB348538 trachea SLC25A37.e-u 3758 to 4293 538 to 1       538/538
(100 %)
1 diff
(99.9 %id)
DB309247 hippocampus SLC25A37.e-u 3776 to 4293 520 to 1   to resequence,   520/520
(100 %)
1 diff
(99.9 %id)
CR592142 Neuroblastoma Cot 25-normalized SLC25A37.f 1 to 1048 1 to 1048 exact tiling clone,   1048/1048
(100 %)
0 diff
(100 %id)
AY032628   SLC25A37.g 1 to 3394 1 to 3397 exact tiling clone, AAA Possibly primed on the genome, locally A rich (45/45 A in genome downstream of last aligned base) 3397/3397
(100 %)
15 diff
(99.6 %id)
BX400897   SLC25A37.g 9 to 1064 1 to 1049 S5R G6X S10Q Q11P A12G ... tiling clone,   1049/1051
(99 %)
14 diff
(98.7 %id)
BX496567 Liver SLC25A37.g 460 to 999 1 to 538       538/538
(100 %)
2 diff
(99.7 %id)
TI_57176274   SLC25A37.g 500 to 1059 83 to 661       579/886
(65 %)
6 diff
(99.4 %id)
BQ014842 Chondrosarcoma, Left Pubic Bone SLC25A37.g 580 to 1296 733 to 19   AAA   715/715
(100 %)
6 diff
(99.2 %id)
DA672861   SLC25A37.g 744 to 1334 2 to 593   capped   592/592
(100 %)
1 diff
(99.9 %id)
AI076690 liver and spleen SLC25A37.g 757 to 1201 2 to 446   AAA Submitted on the opposite strand 445/446
(99 %)
9 diff
(98.0 %id)
TI_57182297   SLC25A37.g 758 to 1448 148 to 838       691/841
(82 %)
9 diff
(99.0 %id)
R96556 liver and spleen SLC25A37.g 776 to 1164 405 to 10     Submitted on the opposite strand 396/409
(96 %)
0 diff
(100 %id)
H40449 liver and spleen SLC25A37.g 784 to 1145 5 to 374     Submitted on the opposite strand 370/404
(91 %)
14 diff
(96.6 %id)
R96511 liver and spleen SLC25A37.g 789 to 1157 1 to 381     Submitted on the opposite strand 381/417
(91 %)
17 diff
(96.0 %id)
BX455861 B cells (Ramos cell line) SLC25A37.g 797 to 1720 929 to 5       925/936
(98 %)
0 diff
(100 %id)
H40448 liver and spleen SLC25A37.g 823 to 1086 266 to 1     Submitted on the opposite strand 266/270
(98 %)
4 diff
(98.6 %id)
AI133036 Liver SLC25A37.g 882 to 1145 1 to 264       264/264
(100 %)
0 diff
(100 %id)
CN372054 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 SLC25A37.g 919 to 1298 1 to 380       380/380
(100 %)
0 diff
(100 %id)
W04455 liver and spleen SLC25A37.g 920 to 1159 241 to 2     Submitted on the opposite strand 240/241
(99 %)
0 diff
(100 %id)
AI655820 pooled germ cell tumors SLC25A37.g 936 to 1296 361 to 1       361/361
(100 %)
0 diff
(100 %id)
BX644852   SLC25A37.g 983 to 1782 13 to 814       802/814
(98 %)
6 diff
(99.3 %id)
CB108744 Liver SLC25A37.g 1060 to 1628 1 to 569       569/569
(100 %)
0 diff
(100 %id)
AW408556 lymph SLC25A37.g 1087 to 1523 1 to 437       437/437
(100 %)
3 diff
(99.4 %id)
TI_154148362   SLC25A37.g 1091 to 1651 76 to 636       561/562
(99 %)
5 diff
(99.2 %id)
BX497413 Liver SLC25A37.g 1146 to 1770 1 to 625       625/627
(99 %)
4 diff
(99.4 %id)
AI305115 Liver SLC25A37.g 1156 to 1811 1 to 657       657/657
(100 %)
5 diff
(99.3 %id)
DN993678 brain, whole brain SLC25A37.g 1163 to 1726 1 to 564       564/564
(100 %)
5 diff
(99.2 %id)
BX421329 B cells (Ramos cell line) SLC25A37.g 1165 to 1697 532 to 1       532/536
(99 %)
11 diff
(98.0 %id)
GD143448   SLC25A37.g 1176 to 1282 1 to 106       106/117
(90 %)
5 diff
(95.8 %id)
AI110794 Liver SLC25A37.g 1195 to 1700 1 to 506       506/506
(100 %)
0 diff
(100 %id)
AF074701 Liver SLC25A37.g 1195 to 1700 1 to 506       506/506
(100 %)
0 diff
(100 %id)
AF116630 Liver SLC25A37.g 1198 to 2773 1 to 1575       1575/1575
(100 %)
2 diff
(99.9 %id)
AI114681 Liver SLC25A37.g 1198 to 1788 1 to 591       591/591
(100 %)
2 diff
(99.7 %id)
BF929847 nervous_tumor SLC25A37.g 1198 to 1605 1 to 408       408/408
(100 %)
3 diff
(99.3 %id)
DA351487 substantia nigra SLC25A37.g 1277 to 1862 2 to 587   capped   586/586
(100 %)
1 diff
(99.9 %id)
DB166019 thyroid gland SLC25A37.g 1303 to 1794 234 to 724   capped   491/723
(67 %)
6 diff
(99.2 %id)
BX644800   SLC25A37.g 1337 to 1789 1 to 453       453/453
(100 %)
1 diff
(99.8 %id)
CA487308   SLC25A37.g 1401 to 2247 1 to 842       842/873
(96 %)
16 diff
(98.2 %id)
BX503388 Liver SLC25A37.g 1407 to 1728 1 to 322   AAA   322/322
(100 %)
0 diff
(100 %id)
CA453937   SLC25A37.g 1422 to 2303 29 to 904       876/904
(96 %)
6 diff
(99.4 %id)
CA454909   SLC25A37.g 1461 to 2330 1 to 874       874/900
(97 %)
20 diff
(97.8 %id)
AI065009 Liver SLC25A37.g 1517 to 1958 442 to 1       442/442
(100 %)
2 diff
(99.6 %id)
AK314731 Prostate SLC25A37.g 1549 to 1849 1 to 301       301/301
(100 %)
1 diff
(99.7 %id)
DA869844 Prostate SLC25A37.g 1550 to 2022 2 to 468   tiling clone, capped   467/467
(100 %)
2 diff
(99.6 %id)
DB493591 hypothalamus SLC25A37.g 1720 to 2228 1 to 510       510/510
(100 %)
11 diff
(97.9 %id)
BU850255 ovary, teratocarcinoma, cell line SLC25A37.g 1738 to 2643 1 to 906       906/908
(99 %)
13 diff
(98.6 %id)
AI064752 Liver SLC25A37.g 1801 to 2265 460 to 1       460/460
(100 %)
2 diff
(99.6 %id)
AI114822 Liver SLC25A37.g 1978 to 2640 9 to 674   tiling clone,   666/674
(98 %)
10 diff
(98.6 %id)
AA837316 germinal center B cell SLC25A37.g 1990 to 2487 1 to 497       497/497
(100 %)
3 diff
(99.4 %id)
R92925 liver and spleen SLC25A37.g 2001 to 2468 1 to 477     Submitted on the opposite strand 477/477
(100 %)
17 diff
(96.5 %id)
H73792 liver and spleen SLC25A37.g 2001 to 2413 1 to 416     Submitted on the opposite strand 416/418
(99 %)
11 diff
(97.4 %id)
AA939056 pooled SLC25A37.g 2001 to 2336 1 to 336     Submitted on the opposite strand 336/336
(100 %)
0 diff
(100 %id)
H73779 liver and spleen SLC25A37.g 2002 to 2389 1 to 392     Submitted on the opposite strand 392/392
(100 %)
7 diff
(98.3 %id)
H93303 liver and spleen SLC25A37.g 2002 to 2431 1 to 432     Submitted on the opposite strand 432/432
(100 %)
4 diff
(99.1 %id)
N58304 liver and spleen SLC25A37.g 2002 to 2451 1 to 461     Submitted on the opposite strand 461/475
(97 %)
23 diff
(95.2 %id)
AF155660 adrenal gland SLC25A37.g 2004 to 3394 1 to 1392   AAA Possibly primed on the genome, locally A rich (45/45 A in genome downstream of last aligned base) 1392/1392
(100 %)
1 diff
(100.0 %id)
N39344 liver and spleen SLC25A37.g 2004 to 2344 1 to 341     Submitted on the opposite strand 341/341
(100 %)
0 diff
(100 %id)
N52417 liver and spleen SLC25A37.g 2004 to 2376 1 to 378     Submitted on the opposite strand 378/384
(98 %)
8 diff
(98.0 %id)
N63741 liver and spleen SLC25A37.g 2004 to 2365 1 to 365     Submitted on the opposite strand 365/396
(92 %)
7 diff
(98.3 %id)
N69573 liver and spleen SLC25A37.g 2004 to 2436 1 to 435     Submitted on the opposite strand 435/437
(99 %)
5 diff
(98.9 %id)
N71587 liver and spleen SLC25A37.g 2004 to 2188 1 to 186     Submitted on the opposite strand 186/190
(97 %)
2 diff
(99.0 %id)
H78806 liver and spleen SLC25A37.g 2008 to 2454 1 to 454     Submitted on the opposite strand 454/456
(99 %)
25 diff
(94.6 %id)
AI630220 blood SLC25A37.g 2010 to 2357 348 to 1       348/348
(100 %)
0 diff
(100 %id)
CN389170 embryonic stem cells, DMSO-treated H9 cellline SLC25A37.g 2011 to 2697 1 to 687       687/687
(100 %)
0 diff
(100 %id)
H56071 liver and spleen SLC25A37.g 2011 to 2344 1 to 334     Submitted on the opposite strand 334/338
(98 %)
1 diff
(99.8 %id)
AF113696 Liver SLC25A37.g 2021 to 2773 1 to 753       753/753
(100 %)
4 diff
(99.5 %id)
AI114773 Liver SLC25A37.g 2021 to 2696 1 to 675       675/675
(100 %)
7 diff
(99.0 %id)
AI186011 lung SLC25A37.g 2022 to 2493 472 to 1       472/472
(100 %)
0 diff
(100 %id)
H91049 liver and spleen SLC25A37.g 2037 to 2223 1 to 187     Submitted on the opposite strand 187/187
(100 %)
0 diff
(100 %id)
AI191379 lung SLC25A37.g 2042 to 2507 470 to 5       466/470
(99 %)
0 diff
(100 %id)
AI065060 Liver SLC25A37.g 2048 to 2700 1 to 653       653/653
(100 %)
1 diff
(99.9 %id)
BP267907 thyroid SLC25A37.g 2057 to 2634 1 to 579       579/579
(100 %)
2 diff
(99.7 %id)
R63761 placenta SLC25A37.g 2059 to 2408 1 to 353   fully sequenced,   353/353
(100 %)
4 diff
(98.9 %id)
H72984 liver and spleen SLC25A37.g 2124 to 2664 561 to 1     Submitted on the opposite strand 561/567
(98 %)
43 diff
(92.5 %id)
ES308133 beard hair, skin SLC25A37.g 2125 to 2274 1 to 152       152/152
(100 %)
7 diff
(95.4 %id)
H56267 liver and spleen SLC25A37.g 2144 to 2639 500 to 5     Submitted on the opposite strand 496/500
(99 %)
10 diff
(98.0 %id)
N91093 liver and spleen SLC25A37.g 2159 to 2639 488 to 7     Submitted on the opposite strand 482/488
(98 %)
3 diff
(99.4 %id)
CB161066 Liver SLC25A37.g 2218 to 2748 531 to 1     Submitted on the opposite strand 531/531
(100 %)
0 diff
(100 %id)
N77670 liver and spleen SLC25A37.g 2226 to 2639 417 to 1     Submitted on the opposite strand 417/417
(100 %)
3 diff
(99.3 %id)
AA827913 germinal center B cell SLC25A37.g 2243 to 2714 472 to 1       472/472
(100 %)
0 diff
(100 %id)
BF792505 adrenal cortex carcinoma, cell line, adrenal gland SLC25A37.g 2249 to 2591 319 to 674       523/716
(73 %)
14 diff
(98.1 %id)
AW516553 cervix, tumor SLC25A37.g 2255 to 2781 527 to 1       527/527
(100 %)
1 diff
(99.9 %id)
BF834392 head_neck SLC25A37.g 2271 to 2628 359 to 4     Submitted on the opposite strand 356/359
(99 %)
0 diff
(100 %id)
AW167688 cervix SLC25A37.g 2278 to 2746 470 to 1       470/470
(100 %)
2 diff
(99.6 %id)
AI374588   SLC25A37.g 2286 to 2763 478 to 1       478/478
(100 %)
0 diff
(100 %id)
AW293894   SLC25A37.g 2287 to 2780 495 to 1       495/495
(100 %)
1 diff
(99.8 %id)
BE675923 B-cell, chronic lymphotic leukemia SLC25A37.g 2294 to 2739 447 to 1       447/447
(100 %)
2 diff
(99.6 %id)
AI015206   SLC25A37.g 2295 to 2781 487 to 1       487/487
(100 %)
2 diff
(99.6 %id)
AI094135 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus SLC25A37.g 2304 to 2756 452 to 1       452/452
(100 %)
3 diff
(99.4 %id)
AI082415 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus SLC25A37.g 2306 to 2781 476 to 1       476/476
(100 %)
1 diff
(99.8 %id)
N45189 liver and spleen SLC25A37.g 2332 to 2552 222 to 1     Submitted on the opposite strand 222/222
(100 %)
2 diff
(99.1 %id)
CN389171 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells SLC25A37.g 2333 to 2830 1 to 498       498/498
(100 %)
0 diff
(100 %id)
AA962551 Kidney SLC25A37.g 2345 to 2749 405 to 1       405/405
(100 %)
2 diff
(99.6 %id)
AW661858 pooled SLC25A37.g 2347 to 2781 437 to 1       437/437
(100 %)
4 diff
(99.1 %id)
CN389168 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells SLC25A37.g 2363 to 2951 1 to 589       589/589
(100 %)
0 diff
(100 %id)
R63715 placenta SLC25A37.g 2378 to 2749 373 to 1   fully sequenced,   373/373
(100 %)
3 diff
(99.2 %id)
H91341 liver and spleen SLC25A37.g 2384 to 2639 274 to 19     Submitted on the opposite strand 256/277
(92 %)
0 diff
(100 %id)
N94063 liver and spleen SLC25A37.g 2393 to 2662 272 to 3     Submitted on the opposite strand 270/275
(98 %)
0 diff
(100 %id)
BF732747 fibrotheoma, ovary SLC25A37.g 2397 to 2781 385 to 1       385/385
(100 %)
0 diff
(100 %id)
BF742347 breast SLC25A37.g 2424 to 2816 393 to 5     Submitted on the opposite strand 389/393
(98 %)
8 diff
(98.0 %id)
AV701391 adrenal gland SLC25A37.g 2429 to 3026 1 to 598       598/598
(100 %)
5 diff
(99.2 %id)
AI612859 ovary, tumor, 5 pooled (see description) SLC25A37.g 2451 to 2727 277 to 1       277/277
(100 %)
0 diff
(100 %id)
DA671675   SLC25A37.h 1 to 572 2 to 573 I40M Y111C G141S tiling clone, capped   572/572
(100 %)
3 diff
(99.5 %id)
DA851989 placenta SLC25A37.i-u 1 to 541 2 to 542   tiling clone, capped   541/541
(100 %)
1 diff
(99.9 %id)
DB130661 thymus SLC25A37.i-u 67 to 587 2 to 523   tiling clone, capped   522/522
(100 %)
2 diff
(99.7 %id)
AW408603 lymph SLC25A37.i-u 120 to 295 189 to 14     Submitted on the opposite strand 176/189
(93 %)
0 diff
(100 %id)
DA458459 tongue, tumor tissue SLC25A37.i-u 138 to 707 2 to 570   capped   569/569
(100 %)
2 diff
(99.7 %id)
AA382004   SLC25A37.i-u 176 to 440 1 to 265       265/265
(100 %)
1 diff
(99.7 %id)
DB165964 thyroid gland SLC25A37.i-u 281 to 1078 2 to 801   tiling clone, capped   800/800
(100 %)
10 diff
(98.8 %id)
DB139984 thymus SLC25A37.i-u 376 to 943 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
DB255358 uterus SLC25A37.i-u 386 to 946 2 to 563   capped   562/562
(100 %)
1 diff
(99.9 %id)
AF495725   SLC25A37.i-u 389 to 3206 1 to 2818 exact tiling clone, AAA   2818/2818
(100 %)
4 diff
(99.9 %id)
AI880107 astrocytoma, brain SLC25A37.i-u 423 to 665 1 to 243     Submitted on the opposite strand 243/245
(99 %)
2 diff
(99.2 %id)
BX506587 Liver SLC25A37.i-u 447 to 1041 1 to 595       595/595
(100 %)
1 diff
(99.9 %id)
BF814098 colon_ins SLC25A37.i-u 528 to 943 418 to 3     Submitted on the opposite strand 416/418
(99 %)
0 diff
(100 %id)
AA346871 heart SLC25A37.i-u 579 to 811 1 to 233       233/233
(100 %)
4 diff
(98.3 %id)
CN292006 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 SLC25A37.i-u 603 to 1335 1 to 733       733/733
(100 %)
0 diff
(100 %id)
CN293889 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 SLC25A37.i-u 608 to 1036 1 to 429       429/429
(100 %)
4 diff
(99.1 %id)
DA041201 bladder SLC25A37.i-u 696 to 1259 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
BU152963 large cell carcinoma, lung SLC25A37.i-u 727 to 1572 12 to 865       854/865
(98 %)
12 diff
(98.7 %id)
DA872632 Prostate SLC25A37.i-u 729 to 1285 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
DA254835 caudate nucleus SLC25A37.i-u 784 to 1330 2 to 548   capped   547/547
(100 %)
1 diff
(99.9 %id)
BU663009 blood SLC25A37.i-u 800 to 1073 1 to 274       274/274
(100 %)
0 diff
(100 %id)
DA279641 corpus callosum SLC25A37.i-u 845 to 1422 2 to 579   capped   578/578
(100 %)
0 diff
(100 %id)
DA866367 Prostate SLC25A37.i-u 889 to 1424 2 to 537   capped   536/536
(100 %)
0 diff
(100 %id)
DA867021 Prostate SLC25A37.i-u 889 to 1436 2 to 549   capped   548/548
(100 %)
0 diff
(100 %id)
BG677722 skin, squamous cell carcinoma SLC25A37.i-u 1054 to 1762 1 to 709 L73V N81K E96D N97T V98C ...     709/710
(99 %)
9 diff
(98.8 %id)
DN998811 bone marrow SLC25A37.i-u 1124 to 1855 1 to 733 exact     733/736
(99 %)
2 diff
(99.8 %id)
CN291167 embryonic stem cells, DMSO-treated H9 cellline SLC25A37.i-u 1135 to 1770 1 to 636 exact     636/636
(100 %)
2 diff
(99.7 %id)
BQ062523 lymph, lymphoma, cell line SLC25A37.i-u 1199 to 2235 1 to 1050 exact available from MGC,   1050/1054
(99 %)
58 diff
(94.5 %id)
BC062364 Lymph, lymphoma SLC25A37.i-u 1200 to 3206 1 to 2007 exact tiling clone, available from MGC, AAA   2007/2007
(100 %)
4 diff
(99.9 %id)
BQ642825 lymph, lymphoma, cell line SLC25A37.i-u 1201 to 1941 1 to 742 exact     742/920
(80 %)
10 diff
(99.0 %id)
BX647289 human bone marrow SLC25A37.i-u 1263 to 3206 1 to 1944 exact available from DKFZ, AAA   1944/1944
(100 %)
6 diff
(99.7 %id)
AI760534 B-cell, chronic lymphotic leukemia SLC25A37.i-u 1285 to 1727 487 to 45 exact AAA   443/463
(95 %)
0 diff
(100 %id)
BP431914   SLC25A37.i-u 1299 to 1703 1 to 405 exact     405/405
(100 %)
2 diff
(99.6 %id)
CD517500 White Matter SLC25A37.i-u 1306 to 2158 1 to 866 exact     866/887
(97 %)
30 diff
(96.7 %id)
AI023428 liver and spleen SLC25A37.i-u 1340 to 1774 437 to 3 T94A     435/437
(99 %)
0 diff
(100 %id)
AW880706 ovary SLC25A37.i-u 1434 to 1762 327 to 1       327/327
(100 %)
1 diff
(99.7 %id)
CA865810 Pancreas, Purified pancreatic islet SLC25A37.i-u 1437 to 1996 1 to 560       560/560
(100 %)
0 diff
(100 %id)
DA677362   SLC25A37.i-u 1478 to 2076 2 to 599   capped   598/598
(100 %)
2 diff
(99.7 %id)
AA311718   SLC25A37.i-u 1535 to 1922 1 to 392       392/392
(100 %)
6 diff
(98.5 %id)
BG708495 brain, hypothalamus SLC25A37.i-u 1559 to 2283 1 to 726       726/726
(100 %)
12 diff
(98.4 %id)
BI598453 brain, hypothalamus SLC25A37.i-u 1559 to 2297 1 to 736   available from MGC,   736/736
(100 %)
11 diff
(98.6 %id)
TI_45212343   SLC25A37.i-u 1563 to 2297 85 to 816       732/816
(89 %)
6 diff
(99.3 %id)
BC042973 Brain, hypothalamus SLC25A37.i-u 1564 to 3206 1 to 1644   available from MGC, AAA   1644/1644
(100 %)
8 diff
(99.6 %id)
BE042780 colon, moderately-differentiated adenocarcinoma SLC25A37.i-u 1567 to 2061 498 to 4       495/498
(99 %)
0 diff
(100 %id)
BE042848 colon, moderately-differentiated adenocarcinoma SLC25A37.i-u 1567 to 2061 498 to 4       495/498
(99 %)
0 diff
(100 %id)
DB498328 hypothalamus SLC25A37.i-u 1575 to 2099 1 to 526       526/526
(100 %)
1 diff
(99.9 %id)
AA343422 adrenal gland SLC25A37.i-u 1580 to 1839 1 to 260       260/260
(100 %)
1 diff
(99.7 %id)
BE042810 colon, moderately-differentiated adenocarcinoma SLC25A37.i-u 1625 to 2061 440 to 4       437/440
(99 %)
0 diff
(100 %id)
BM552610 astrocytoma grade IV, cell line, brain SLC25A37.i-u 1651 to 2579 1 to 939       939/1036
(90 %)
34 diff
(96.8 %id)
BM910635 astrocytoma grade IV, cell line, brain SLC25A37.i-u 1653 to 2639 1 to 994       994/1049
(94 %)
20 diff
(98.1 %id)
BF680988 Prostate SLC25A37.i-u 1679 to 2381 1 to 690       690/783
(88 %)
20 diff
(97.5 %id)
BG251842 adenocarcinoma, cell line, Liver SLC25A37.i-u 1688 to 2429 1 to 733       733/740
(99 %)
13 diff
(98.3 %id)
CN261431 embryonic stem cells, DMSO-treated H9 cellline SLC25A37.i-u 1696 to 2359 1 to 664       664/664
(100 %)
5 diff
(99.3 %id)
CB117016 Liver SLC25A37.i-u 1770 to 2287 1 to 518       518/518
(100 %)
0 diff
(100 %id)
AA348671 brain, hippocampus SLC25A37.i-u 1774 to 2057 1 to 284       284/284
(100 %)
2 diff
(99.3 %id)
CB149576 Liver SLC25A37.i-u 1791 to 2287 1 to 497       497/497
(100 %)
4 diff
(99.2 %id)
TI_154170771   SLC25A37.i-u 1815 to 2431 88 to 709       622/1164
(53 %)
13 diff
(98.9 %id)
BY995659   SLC25A37.i-u 1917 to 2658 1 to 742       742/742
(100 %)
10 diff
(98.7 %id)
BX508701   SLC25A37.i-u 1933 to 2561 1 to 627       627/627
(100 %)
20 diff
(96.9 %id)
BX503914   SLC25A37.i-u 1934 to 2638 1 to 703       703/703
(100 %)
20 diff
(97.2 %id)
AA034423 heart SLC25A37.i-u 1973 to 2592 1 to 618       618/628
(98 %)
26 diff
(95.9 %id)
AA369818 Prostate SLC25A37.i-u 1975 to 2407 1 to 437       437/437
(100 %)
6 diff
(98.7 %id)
AW957099   SLC25A37.i-u 1976 to 2557 1 to 582       582/587
(99 %)
14 diff
(97.7 %id)
S94541   SLC25A37.i-u 2005 to 2544 1 to 540       540/545
(99 %)
6 diff
(98.9 %id)
H59392 liver and spleen SLC25A37.i-u 2190 to 2421 92 to 325       234/325
(72 %)
4 diff
(98.8 %id)
AA033741 heart SLC25A37.i-u 2196 to 2699 1 to 504     Submitted on the opposite strand 504/504
(100 %)
4 diff
(99.3 %id)
AA481837 ovarian tumor, ovary SLC25A37.i-u 2201 to 2754 1 to 554       554/554
(100 %)
2 diff
(99.7 %id)
AA410916 ovarian tumor, ovary SLC25A37.i-u 2204 to 2668 1 to 464       464/464
(100 %)
3 diff
(99.4 %id)
AV702441 adrenal gland SLC25A37.i-u 2219 to 2851 1 to 631       631/633
(99 %)
11 diff
(98.3 %id)
CN265221 embryonic stem cells, cell lines H1, H7, andH9 SLC25A37.i-u 2247 to 2771 21 to 545       525/545
(96 %)
6 diff
(98.9 %id)
TI_149278387   SLC25A37.i-u 2290 to 3206 1000 to 93   AAA   908/1112
(81 %)
26 diff
(97.7 %id)
TI_159699141   SLC25A37.i-u 2320 to 3206 973 to 87   AAA   887/1053
(84 %)
8 diff
(99.3 %id)
N98447 liver and spleen SLC25A37.i-u 2335 to 2684 1 to 348   fully sequenced,   348/348
(100 %)
1 diff
(99.8 %id)
R96659 liver and spleen SLC25A37.i-u 2393 to 2720 1 to 330   tiling clone,   330/332
(99 %)
5 diff
(98.5 %id)
H93933 liver and spleen SLC25A37.i-u 2393 to 2717 1 to 325       325/429
(75 %)
2 diff
(99.6 %id)
W77879 heart SLC25A37.i-u 2395 to 2824 1 to 430       430/430
(100 %)
2 diff
(99.6 %id)
AA486824 lung SLC25A37.i-u 2395 to 2749 1 to 353       353/353
(100 %)
6 diff
(98.4 %id)
H94411 liver and spleen SLC25A37.i-u 2402 to 2796 1 to 401   fully sequenced,   401/401
(100 %)
11 diff
(97.3 %id)
AI123826 pooled SLC25A37.i-u 2459 to 3206 766 to 15   AAA   752/752
(100 %)
23 diff
(97.0 %id)
TI_154105185   SLC25A37.i-u 2489 to 3206 811 to 94   AAA   718/718
(100 %)
7 diff
(99.1 %id)
R92068 liver and spleen SLC25A37.i-u 2508 to 2823 1 to 317   fully sequenced,   317/317
(100 %)
3 diff
(99.1 %id)
BQ010194 Chondrosarcoma, Left Pubic Bone SLC25A37.i-u 2521 to 3206 704 to 19   AAA   686/686
(100 %)
2 diff
(99.8 %id)
BQ773694 Chondrosarcoma Grade II, Left Pelvis SLC25A37.i-u 2526 to 3206 699 to 19   AAA   681/682
(99 %)
3 diff
(99.6 %id)
CA420791 Bone, Enchondroma cell line SLC25A37.i-u 2539 to 3206 686 to 19   AAA   668/668
(100 %)
3 diff
(99.6 %id)
BU678460 lung SLC25A37.i-u 2543 to 3206 682 to 19   AAA   664/664
(100 %)
3 diff
(99.6 %id)
CA446464 Chondrosarcoma, Left Pubic Bone SLC25A37.i-u 2543 to 3206 682 to 19   AAA   664/664
(100 %)
4 diff
(99.4 %id)
AA316186 colon SLC25A37.i-u 2573 to 3115 1 to 544       544/544
(100 %)
3 diff
(99.5 %id)
DB329675 Prostate SLC25A37.i-u 2620 to 3206 587 to 1       587/587
(100 %)
1 diff
(99.9 %id)
CA865553 Pancreas, Purified pancreatic islet SLC25A37.i-u 2629 to 3208 583 to 4       580/583
(99 %)
0 diff
(100 %id)
BQ005415 Chondrosarcoma, Left Pelvis SLC25A37.i-u 2630 to 3208 593 to 17       577/593
(97 %)
0 diff
(100 %id)
TI_149292768   SLC25A37.i-u 2640 to 3206 649 to 86   AAA   564/685
(82 %)
30 diff
(95.7 %id)
N63920 liver and spleen SLC25A37.i-u 2654 to 3206 547 to 1   fully sequenced,   547/547
(100 %)
8 diff
(98.6 %id)
DB381834 thyroid gland SLC25A37.i-u 2659 to 3206 557 to 1       557/578
(96 %)
24 diff
(95.9 %id)
DB344552 thymus SLC25A37.i-u 2673 to 3206 534 to 1       534/534
(100 %)
1 diff
(99.9 %id)
AW999462 breast_normal SLC25A37.i-u 2690 to 2817 128 to 1     Submitted on the opposite strand 128/128
(100 %)
0 diff
(100 %id)
BF109368 pooled SLC25A37.i-u 2696 to 3208 519 to 7       513/519
(98 %)
0 diff
(100 %id)
AI186718 lung SLC25A37.i-u 2697 to 3207 512 to 1       512/512
(100 %)
2 diff
(99.7 %id)
AI985717 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors SLC25A37.i-u 2714 to 3206 494 to 1       494/494
(100 %)
5 diff
(99.0 %id)
AI201945 Prostate SLC25A37.i-u 2730 to 3206 488 to 12   AAA   477/482
(98 %)
2 diff
(99.6 %id)
DB569421 hypothalamus SLC25A37.i-u 2736 to 3206 1 to 471     Submitted on the opposite strand 471/471
(100 %)
5 diff
(99.0 %id)
H93069 liver and spleen SLC25A37.i-u 2750 to 3206 457 to 1       457/457
(100 %)
1 diff
(99.8 %id)
N74503 liver and spleen SLC25A37.i-u 2755 to 3206 453 to 1       453/453
(100 %)
2 diff
(99.6 %id)
AI083749 anaplastic oligodendroglioma, brain SLC25A37.i-u 2755 to 3206 462 to 11   AAA   452/452
(100 %)
1 diff
(99.8 %id)
BM695394 eye, optic nerve SLC25A37.i-u 2758 to 3206 1 to 449   AAA   449/449
(100 %)
1 diff
(99.8 %id)
AI090840   SLC25A37.i-u 2763 to 3208 446 to 1       446/446
(100 %)
2 diff
(99.6 %id)
AI089596 uterus SLC25A37.i-u 2764 to 3206 443 to 1       443/443
(100 %)
1 diff
(99.8 %id)
AI161383 heart SLC25A37.i-u 2768 to 3205 463 to 26   AAA   438/438
(100 %)
18 diff
(95.9 %id)
CB105870 Liver SLC25A37.i-u 2770 to 3208 1 to 439   tiling clone,   439/439
(100 %)
1 diff
(99.8 %id)
CD722450 eye, lacrimal gland SLC25A37.i-u 2770 to 3205 1 to 436       436/436
(100 %)
1 diff
(99.8 %id)
H97994 melanocyte SLC25A37.i-u 2778 to 3206 429 to 1       429/429
(100 %)
2 diff
(99.6 %id)
AI520700 adenocarcinoma, Pancreas SLC25A37.i-u 2789 to 3206 432 to 15   AAA   418/418
(100 %)
4 diff
(99.1 %id)
AA507102 Prostate SLC25A37.i-u 2790 to 3133 21 to 364       344/371
(92 %)
3 diff
(99.2 %id)
H94319 liver and spleen SLC25A37.i-u 2792 to 3208 420 to 1   fully sequenced,   420/420
(100 %)
4 diff
(99.1 %id)
R92022 liver and spleen SLC25A37.i-u 2793 to 3200 412 to 1   fully sequenced,   412/412
(100 %)
12 diff
(97.1 %id)
AA676230 liver and spleen SLC25A37.i-u 2797 to 3206 410 to 1       410/410
(100 %)
4 diff
(99.1 %id)
BF509633   SLC25A37.i-u 2801 to 3206 423 to 18   AAA   406/480
(84 %)
3 diff
(99.4 %id)
AA112480   SLC25A37.i-u 2803 to 3206 423 to 20   AAA   404/404
(100 %)
1 diff
(99.8 %id)
AA487146 lung SLC25A37.i-u 2806 to 3208 404 to 2       403/404
(99 %)
0 diff
(100 %id)
DB513856 testis SLC25A37.i-u 2809 to 3205 1 to 397     Submitted on the opposite strand 397/397
(100 %)
5 diff
(98.8 %id)
AI446584 poorly differentiated adenocarcinoma withsignet ring cell features, stomach SLC25A37.i-u 2815 to 3208 400 to 7       394/400
(98 %)
0 diff
(100 %id)
AI283012 placenta SLC25A37.i-u 2822 to 3208 391 to 5       387/391
(98 %)
0 diff
(100 %id)
TI_149279713   SLC25A37.i-u 2823 to 3194 443 to 72       372/1183
(31 %)
0 diff
(100 %id)
BM969719 lung, Primary Lung Epithelial Cells SLC25A37.i-u 2823 to 3194 400 to 29   AAA   372/397
(93 %)
0 diff
(100 %id)
W72637 heart SLC25A37.i-u 2837 to 3205 371 to 3       369/371
(99 %)
0 diff
(100 %id)
AA053887 heart SLC25A37.i-u 2847 to 3206 384 to 22   AAA   363/363
(100 %)
8 diff
(97.8 %id)
BE218520 carcinoid, lung SLC25A37.i-u 2852 to 3184 1 to 333     Submitted on the opposite strand 333/333
(100 %)
1 diff
(99.7 %id)
W74045 Pancreas, pancreatic islet SLC25A37.i-u 2859 to 3208 362 to 5     Submitted on the opposite strand 358/385
(92 %)
0 diff
(100 %id)
AA369817 Prostate SLC25A37.i-u 2872 to 3206 335 to 1       335/336
(99 %)
1 diff
(99.8 %id)
AA456584 ovarian tumor, ovary SLC25A37.i-u 2925 to 3206 292 to 11   AAA   282/282
(100 %)
1 diff
(99.7 %id)
BM974830 lung SLC25A37.i-u 2925 to 3206 300 to 19   AAA   282/282
(100 %)
1 diff
(99.7 %id)
AI864576 anaplastic oligodendroglioma, brain SLC25A37.i-u 2928 to 3208 282 to 2       281/282
(99 %)
0 diff
(100 %id)
AA382003   SLC25A37.i-u 2944 to 3206 263 to 1       263/263
(100 %)
3 diff
(98.9 %id)
R96619 liver and spleen SLC25A37.i-u 2950 to 3170 221 to 1       221/221
(100 %)
2 diff
(99.1 %id)
AW089274 brain, tumor, 5 pooled (see description) SLC25A37.i-u 3000 to 3208 210 to 2       209/210
(99 %)
0 diff
(100 %id)
AA033740 heart SLC25A37.i-u 3026 to 3178 153 to 1     Submitted on the opposite strand 153/153
(100 %)
1 diff
(99.4 %id)
AA424188   SLC25A37.j 1 to 232 9 to 239   fully sequenced,   239/239
(100 %)
3 diff
(98.8 %id)
AA724835 pooled SLC25A37.j 2 to 349 351 to 4       348/351
(99 %)
0 diff
(100 %id)
AW291952   SLC25A37.j 3 to 439 457 to 20   tiling clone,   438/457
(95 %)
8 diff
(98.3 %id)
AA029742 heart SLC25A37.j 5 to 429 1 to 425   fully sequenced,   425/425
(100 %)
4 diff
(99.1 %id)
AI243810 pooled SLC25A37.j 7 to 441 435 to 1       435/435
(100 %)
0 diff
(100 %id)
BQ011554 placenta SLC25A37.j 12 to 436 443 to 19   AAA   425/427
(99 %)
4 diff
(99.1 %id)
AI307165 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus SLC25A37.j 61 to 441 381 to 1       381/381
(100 %)
0 diff
(100 %id)
BF939627 Kidney SLC25A37.j 95 to 461 367 to 1   tiling clone,   367/367
(100 %)
0 diff
(100 %id)
C02500   SLC25A37.j 159 to 442 1 to 284       284/285
(99 %)
1 diff
(99.7 %id)
AA424146   SLC25A37.j 171 to 443 278 to 6   fully sequenced,   273/278
(98 %)
0 diff
(100 %id)
AI382455   SLC25A37.j 200 to 441 261 to 20   AAA   242/243
(99 %)
3 diff
(98.8 %id)
AA029692 heart SLC25A37.j 300 to 442 143 to 1   fully sequenced,   143/143
(100 %)
0 diff
(100 %id)
BX449089 fetal liver, Liver SLC25A37.k-u 1 to 1022 1 to 1016 R6X A9X C30X F34X L37X ... tiling clone,   1016/1026
(99 %)
27 diff
(97.4 %id)
BI912248 leukocyte SLC25A37.k-u 171 to 736 12 to 582 L12V P13T C14L G16R S17L ... tiling clone,   571/582
(98 %)
6 diff
(99.0 %id)
TI_57236263   SLC25A37.k-u 171 to 736 12 to 582 L12V P13T C14L G16R S17L ...     571/582
(98 %)
6 diff
(99.0 %id)
AA001350.
matches multiple genes
liver and spleen SLC25A37.k-u 735 to 1160 1 to 426     also hits gene FBP1 426/426
(100 %)
4 diff
(99.1 %id)
AA203114 liver and spleen SLC25A37.k-u 735 to 1303 1 to 563   tiling clone,   563/852
(66 %)
11 diff
(98.8 %id)
H83070 liver and spleen SLC25A37.k-u 787 to 1030 1 to 244       244/244
(100 %)
1 diff
(99.6 %id)
R00660 liver and spleen SLC25A37.k-u 816 to 1105 1 to 293       293/319
(91 %)
5 diff
(98.5 %id)
H70366 liver and spleen SLC25A37.k-u 989 to 1386 12 to 413   tiling clone,   402/415
(96 %)
5 diff
(98.8 %id)
R95157 liver and spleen SLC25A37.k-u 1053 to 1352 1 to 306   tiling clone,   306/309
(99 %)
9 diff
(97.1 %id)
BX449088 fetal liver, Liver SLC25A37.k-u 1429 to 1951 541 to 19   tiling clone,   523/894
(58 %)
0 diff
(100 %id)
AW468291 myeloid cells, 18 pooled CML cases, BCR/ABLrearrangement positive, includes both chronic phase andmyeloid blast crisis, whole blood SLC25A37.k-u 1522 to 1794 271 to 1   tiling clone,   271/271
(100 %)
2 diff
(99.3 %id)
AA704777 liver and spleen SLC25A37.k-u 1525 to 1987 463 to 1   tiling clone,   463/463
(100 %)
0 diff
(100 %id)
AA001981.
matches multiple genes
liver and spleen SLC25A37.k-u 1563 to 1987 426 to 1     also hits gene FBP1 426/426
(100 %)
1 diff
(99.8 %id)
AI078348 liver and spleen SLC25A37.k-u 1586 to 1987 402 to 1       402/402
(100 %)
0 diff
(100 %id)
H82849 liver and spleen SLC25A37.k-u 1587 to 1891 312 to 5       308/322
(95 %)
0 diff
(100 %id)
AW468277 myeloid cells, 18 pooled CML cases, BCR/ABLrearrangement positive, includes both chronic phase andmyeloid blast crisis, whole blood SLC25A37.k-u 1587 to 1794 206 to 1       206/206
(100 %)
1 diff
(99.6 %id)
H69701 liver and spleen SLC25A37.k-u 1596 to 1991 413 to 6   tiling clone,   408/413
(98 %)
0 diff
(100 %id)
AJ715191 bone marrow SLC25A37.k-u 1612 to 1902 1 to 292       292/292
(100 %)
1 diff
(99.7 %id)
R00554 liver and spleen SLC25A37.k-u 1688 to 1983 312 to 6       307/332
(92 %)
0 diff
(100 %id)
BM922907 leukocyte SLC25A37.l 1 to 811 7 to 822       822/1076
(76 %)
43 diff
(96.1 %id)
BM559642 brain, medulla SLC25A37.l 1 to 889 24 to 920   tiling clone,   901/1074
(83 %)
28 diff
(97.4 %id)
DA388002 thalamus SLC25A37.l 19 to 598 2 to 582   capped   581/581
(100 %)
1 diff
(99.9 %id)
BM543582 brain, hippocampus SLC25A37.l 29 to 811 13 to 802       790/1037
(76 %)
27 diff
(97.4 %id)
DA010264 adrenal gland SLC25A37.l 70 to 638 2 to 570   capped   569/569
(100 %)
1 diff
(99.9 %id)
DA825409 pericardium SLC25A37.l 70 to 621 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
DB133744 thymus SLC25A37.l 82 to 629 2 to 549   capped   548/548
(100 %)
1 diff
(99.9 %id)
AK223194 Pancreas SLC25A37.l 99 to 1989 1 to 1890 exact tiling clone, AAA Possibly primed on the genome, locally A rich (45/45 A in genome downstream of last aligned base) 1890/1890
(100 %)
3 diff
(99.9 %id)
AK074708   SLC25A37.l 101 to 1989 1 to 1890 F70S tiling clone, available from FLJ,   1890/1890
(100 %)
4 diff
(99.8 %id)
DA670378   SLC25A37.l 102 to 657 2 to 557   capped   556/556
(100 %)
2 diff
(99.7 %id)
DA727719   SLC25A37.l 102 to 720 2 to 620   capped   619/621
(99 %)
4 diff
(99.4 %id)
DA987889 synovial membrane tissue from rheumatioidarthritis SLC25A37.l 102 to 665 2 to 565   capped   564/564
(100 %)
2 diff
(99.7 %id)
DA993372 synovial membrane tissue from rheumatioidarthritis SLC25A37.l 102 to 637 2 to 537   capped   536/536
(100 %)
2 diff
(99.7 %id)
DB024166 testis SLC25A37.l 102 to 659 2 to 560   capped   559/559
(100 %)
3 diff
(99.5 %id)
DN998337 bone marrow SLC25A37.l 113 to 775 1 to 663       663/664
(99 %)
6 diff
(99.1 %id)
BX353259 Neuroblastoma Cot 25-normalized SLC25A37.l 117 to 1120 1 to 1004       1004/1091
(92 %)
7 diff
(99.4 %id)
BX386923 Neuroblastoma Cot 25-normalized SLC25A37.l 117 to 1063 1 to 943       943/943
(100 %)
10 diff
(99.0 %id)
EB385454 eye, optic nerve SLC25A37.l 117 to 807 1 to 691       691/691
(100 %)
2 diff
(99.8 %id)
DA674817   SLC25A37.l 117 to 690 2 to 575   capped   574/574
(100 %)
2 diff
(99.7 %id)
CN389172 embryonic stem cells, DMSO-treated H9 cellline SLC25A37.l 119 to 1017 1 to 899       899/899
(100 %)
9 diff
(99.0 %id)
BF797743 lymph, lymphoma, cell line SLC25A37.l 121 to 860 1 to 739       739/866
(85 %)
15 diff
(98.3 %id)
DB122285 thymus SLC25A37.l 121 to 700 2 to 581   capped   580/580
(100 %)
1 diff
(99.9 %id)
BC015013 Uterus, leiomyosarcoma SLC25A37.l 135 to 980 1 to 846   available from MGC,   846/846
(100 %)
0 diff
(100 %id)
BE882822 leiomyosarcoma, uterus SLC25A37.l 143 to 840 1 to 698   available from MGC,   698/942
(74 %)
6 diff
(99.4 %id)
DB131418 thymus SLC25A37.l 145 to 637 2 to 496   capped   495/495
(100 %)
3 diff
(99.4 %id)
DA625276 Kidney SLC25A37.l 153 to 706 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
DA672219   SLC25A37.l 157 to 737 2 to 582   capped   581/581
(100 %)
0 diff
(100 %id)
BE778106 eye, retinoblastoma SLC25A37.l 172 to 833 1 to 657       657/920
(71 %)
12 diff
(98.7 %id)
AK075313   SLC25A37.l 175 to 1989 1 to 1814 exact available from FLJ,   1814/1814
(100 %)
4 diff
(99.8 %id)
BF796601 lymph, lymphoma, cell line SLC25A37.l 185 to 831 1 to 647       647/795
(81 %)
3 diff
(99.7 %id)
BM313240 Pancreas, Purified pancreatic islet SLC25A37.l 222 to 805 9 to 592       584/592
(98 %)
8 diff
(98.7 %id)
BQ948619 eye, normal pigmented retinal epithelium SLC25A37.l 224 to 1102 1 to 885       883/887
(99 %)
9 diff
(99.0 %id)
N71105 lung SLC25A37.l 254 to 628 109 to 485     Submitted on the opposite strand 377/485
(77 %)
11 diff
(97.8 %id)
AA694186 liver and spleen SLC25A37.l 349 to 965 613 to 1       613/637
(96 %)
10 diff
(98.5 %id)
AW291353   SLC25A37.l 356 to 965 624 to 18   AAA   607/608
(99 %)
5 diff
(99.2 %id)
CB989761 Human Placenta, placenta SLC25A37.l 356 to 1104 31 to 773       743/821
(90 %)
11 diff
(98.7 %id)
BQ083145 Ascites, stomach SLC25A37.l 372 to 813 1 to 442       442/442
(100 %)
1 diff
(99.8 %id)
AA368280 placenta SLC25A37.l 411 to 744 1 to 333       333/333
(100 %)
3 diff
(99.1 %id)
BM312950 Pancreas, Purified pancreatic islet SLC25A37.l 415 to 964 549 to 1       549/549
(100 %)
4 diff
(99.3 %id)
CN389166 embryonic stem cells, DMSO-treated H9 cellline SLC25A37.l 444 to 874 1 to 431       431/431
(100 %)
1 diff
(99.8 %id)
W05848 lung SLC25A37.l 464 to 969 504 to 1     Submitted on the opposite strand 504/504
(100 %)
5 diff
(99.1 %id)
BP391664 pancreatic islet SLC25A37.l 465 to 965 1 to 500     Submitted on the opposite strand 500/500
(100 %)
2 diff
(99.6 %id)
AI478691 colon, moderately-differentiated adenocarcinoma SLC25A37.l 474 to 965 491 to 1       491/491
(100 %)
2 diff
(99.6 %id)
AW296008   SLC25A37.l 510 to 725 14 to 229     Submitted on the opposite strand 216/239
(90 %)
1 diff
(99.6 %id)
AW272206 colon, moderately-differentiated adenocarcinoma SLC25A37.l 529 to 966 437 to 1       437/437
(100 %)
2 diff
(99.6 %id)
AA699405 liver and spleen SLC25A37.l 537 to 965 428 to 1       428/428
(100 %)
2 diff
(99.6 %id)
BQ374909 testis_normal SLC25A37.l 554 to 935 388 to 5       384/390
(98 %)
0 diff
(100 %id)
BQ378609 uterus_tumor SLC25A37.l 555 to 946 393 to 3       391/408
(95 %)
0 diff
(100 %id)
AI091490 pooled SLC25A37.l 559 to 972 414 to 1       414/414
(100 %)
0 diff
(100 %id)
BQ954072 large cell carcinoma, lung SLC25A37.l 564 to 1454 1 to 906       906/914
(99 %)
36 diff
(96.1 %id)
BF912649 uterus_tumor SLC25A37.l 565 to 945 380 to 3     Submitted on the opposite strand 378/380
(99 %)
0 diff
(100 %id)
BQ375177 testis_normal SLC25A37.l 565 to 926 366 to 5       362/366
(98 %)
0 diff
(100 %id)
BQ375218 testis_normal SLC25A37.l 565 to 938 373 to 1       373/373
(100 %)
3 diff
(99.2 %id)
BQ378773 uterus_tumor SLC25A37.l 565 to 963 437 to 43       395/437
(90 %)
0 diff
(100 %id)
AA116050   SLC25A37.l 591 to 1010 1 to 420       420/420
(100 %)
1 diff
(99.8 %id)
BX480864   SLC25A37.l 604 to 1079 1 to 474       474/474
(100 %)
3 diff
(99.4 %id)
AW272224 colon, moderately-differentiated adenocarcinoma SLC25A37.l 628 to 966 338 to 1       338/338
(100 %)
3 diff
(99.2 %id)
TI_57185945   SLC25A37.l 648 to 980 36 to 366   AAA   331/852
(38 %)
5 diff
(99.5 %id)
TI_149274718   SLC25A37.l 859 to 1788 66 to 993 A163X T177N R179X E182X   Submitted on the opposite strand 928/1105
(83 %)
28 diff
(97.5 %id)
AI126552 placenta SLC25A37.l 866 to 1351 486 to 1       486/504
(96 %)
0 diff
(100 %id)
DT217234 brain SLC25A37.l 879 to 1480 1 to 601       601/601
(100 %)
2 diff
(99.7 %id)
BM968576 lung, Primary Lung Epithelial Cells SLC25A37.l 885 to 1546 13 to 674     Submitted on the opposite strand 662/662
(100 %)
0 diff
(100 %id)
BQ017443 lung, Metastatic Chondrosarcoma SLC25A37.l 1018 to 1654 651 to 17 L43W A45L F46L Y47P R48E ... AAA   635/635
(100 %)
4 diff
(99.4 %id)
AA116051   SLC25A37.l 1546 to 1989 444 to 1       444/446
(99 %)
4 diff
(99.2 %id)
BI772322 pooled lung and spleen SLC25A37.m 1 to 802 5 to 825 G42W S43V E44G D45G Y46L ... tiling clone,   825/825
(100 %)
27 diff
(96.8 %id)
TI_57180177   SLC25A37.m 1 to 777 61 to 856 G42W S43V E44G D45G Y46L ...     800/881
(90 %)
44 diff
(95.1 %id)
BX433230 B cells (Ramos cell line) SLC25A37.m 242 to 1163 920 to 1   tiling clone,   920/920
(100 %)
10 diff
(99.0 %id)
BX349128   SLC25A37.m 948 to 1511 7 to 569   tiling clone,   563/569
(98 %)
7 diff
(98.8 %id)
AI816723 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) SLC25A37.m 995 to 1484 488 to 13       476/488
(97 %)
2 diff
(99.6 %id)
DA028632   SLC25A37.n 1 to 570 2 to 571 exact tiling clone, capped   570/570
(100 %)
1 diff
(99.9 %id)
DA670339   SLC25A37.o 1 to 547 2 to 548 L14R L22F tiling clone, capped   547/547
(100 %)
3 diff
(99.5 %id)
63 other accessions, mainly redundant or of lesser quality, also belong to this gene but are not reported.
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d-u, .e-u, .f, .g, .h, .i-u, .j, .k-u, .l, .m, .n, .o Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes C